OTLK 8-K 2026-07-16

Outlook Therapeutics, Inc. (OTLK) 8-K dated 2026-07-16 — accession 0001104659-26-084242. This URL is the filing, not the OTLK hub.

Outlook Therapeutics, Inc. (OTLK) is a biotechnology company listed on US.

Outlook Therapeutics, Inc. filed a 8-K on 2026-07-16. Accession 0001104659-26-084242.

Cached items: 5.03, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported OTLK revenue for 2025-06-30 was $1.5M. Net income was -$20.2M. OTLK currently screens at market cap $68.6M and trailing P/E 0.4.

Not investment advice. The OTLK SEC hub lists recent forms. The stock page is the research view.